Specific Clinical Experience Investigation for Long-term Use of Exenatide (Byetta Subcutaneous Injection)
NCT01817569 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2948
Last updated 2020-07-20
Summary
The purpose of this investigation is to describe general safety profile of type II Diabetes Mellitus (DM) Japanese patients under exenatide therapy in real world medical practices
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Shigeru Yoshida, MD · AstraZeneca
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2011-02-13
- Primary Completion
- 2019-10-03
- Completion
- 2019-10-03
Countries
- Japan
Study Locations
More Related Trials
-
Safety and Tolerability of Lixisenatide in Combination With Oral Anti-Diabetic Treatment in Patients With Type 2 Diabetes
NCT01940965 ·Status: COMPLETED ·Phase: PHASE3
-
To Evaluate the Bioavailability of a Tablet of AZD1656
NCT00817505 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin
NCT00099320 ·Status: COMPLETED ·Phase: PHASE3
-
To Study Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD1656 in Japanese Type 2 Diabetes Mellitus (T2DM) Patients
NCT00916604 ·Status: COMPLETED ·Phase: PHASE1
-
Safety And Tolerability Of Lixisenatide In Monotherapy In Patients With Type 2 Diabetes
NCT01960179 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Exenatide on Fasting Bile Acids
NCT04303819 ·Status: COMPLETED
-
Study to Assess the Safety and Tolerability After Multiple Oral Doses of AZD1656 in Patients With Type 2 Diabetes Mellitus Treated With Metformin
NCT00817778 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Tolerability After Four Weeks of Treatment With AZD1656 in Patients With Type 2 Diabetes
NCT00856908 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Pharmacokinetics, and Pharmacodynamics Study of Single Dose of CNTO 3649 in Healthy Adult Men and Multiple Doses of CNTO 3649 in Participants With Type 2 Diabetes Mellitus
NCT02224118 ·Status: COMPLETED ·Phase: PHASE1
-
To Assess Safety, Tolerability, Pharmacokinetics/Pharmacodynamics and the Effect of Fasting After Single Oral Doses of AZD5658 in Type 2 Diabetes
NCT01176097 ·Status: COMPLETED ·Phase: PHASE1
-
A Single-Center, Open-Label, Single Ascending Dose Study of Exenatide Circular RNA-Lipid Nanoparticle Injection (CR059) in Chinese Subjects With Type 2 Diabetes Mellitus
NCT07347080 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
A Study of LY3549492 in Japanese Participants With Type 2 Diabetes Mellitus (T2D) and Healthy Japanese Participants
NCT06869018 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate Safety and PK/PD of DA-3091 in Healthy Male Subjects
NCT01156779 ·Status: COMPLETED ·Phase: PHASE1
-
Long-Term Safety Study of TA-7284 in Patients With Type 2 Diabetes Mellitus
NCT01387737 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacokinetic/Pharmacodynamic Study of MP-513 With Type 2 Diabetes Mellitus
NCT01072331 ·Status: COMPLETED ·Phase: PHASE3
-
BI 1356 BS in Japanese Patients With Type 2 Diabetes Mellitus
NCT02183324 ·Status: COMPLETED ·Phase: PHASE2
-
A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)
NCT01733758 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerability Study of MEDI0382 in Japanese Preobese or Obese Subjects With Type 2 Diabetes
NCT03645421 ·Status: COMPLETED ·Phase: PHASE2
-
Long-term Safety Study of MP-513 in Patients With Type 2 Diabetes
NCT01301833 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of LY2189265 in Japanese Patients With Type 2 Diabetes
NCT01001104 ·Status: COMPLETED ·Phase: PHASE2
-
SYR-472 Open-label Study
NCT01751360 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacodynamics, Pharmacokinetics, and Safety of ASP1941 in Patients With Type 1 Diabetes Mellitus
NCT02529449 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of TA-7284 in Patients With Type 2 Diabetes
NCT01413204 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin
NCT00701935 ·Status: TERMINATED ·Phase: PHASE2
-
A Single-Dose Study of MK6349 in Patients With Type 2 Diabetes (6349-002)
NCT00943371 ·Status: TERMINATED ·Phase: PHASE1